Sodium selenate as a disease-modifying treatment for mild–moderate Alzheimer’s disease: an open-label extension study
Lucy Vivash, Charles B Malpas, Christopher M Hovens, Amy Brodtmann, Steven Collins, Stephen Macfarlane, Dennis Velakoulis, Terence J O’Brien
BMJ Neurology Open Dec 2021, 3 (2) e000223; DOI: 10.1136/bmjno-2021-000223
